Gastroparesis Market Share, Size, and Outlook by 2031
Gastroparesis Market: Strategic Insights
Gastroparesis Market
-
CAGR (2023 - 2031)4.9% -
Market Size 2023
US$ 5.03 billion -
Market Size 2031
US$ 7.39 billion
Market Dynamics
GROWTH DRIVERS
- Increasing prevelance of Diabetes Mellitus
FUTURE TRENDS
- Technological Advancements and incresaing research on gastric stimulation
OPPORTUNITIES
- Surging Clinical Trials
Key Players
- EVOKE PHARMA
- Bausch Health Companies Inc Salix Pharmaceuticals Ltd
- Johnson And Johnson Services Inc
- Allergan Plc
- NEUROGASTRX INC
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Pfizer Inc
- ANI Pharmaceuticals Inc
- Ipca Laboratories Ltd
- Cinrx Pharma LLC Cindome Pharma
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Type - Idiopathic
- Diabetic
- Post-Surgical
Drug Class Type - Prokinetic Agents
- Antiemetic Agents
- Botulinum Toxin Injection
Distribution Channel - Hospital Pharmacies
- Retail Pharmacies
Get Free Sample For